Download in electronic PDF format for $25



Search the Complete Journal Archives

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States

Author(s):  Lobb William B,Wilkin Noel E,Holmes Erin R

Issue:  Nov/Dec 2015 - Volume 19, Number 6
View All Articles in Issue

Abstract:  Studies have been conducted to assess patient satisfaction with compounded pharmaceuticals and to directly compare compounded pharmaceuticals with their comparable commercial pharmaceuticals. Yet, the economic value of or potential for economic value derived from compounded pharmaceuticals relative to commercial pharmaceuticals is still not known. Therefore, the purpose of this study was to assess and compare compounding and noncompounding pharmacists’ perceptions of the economic value of compounded preparations relative to commercial products. In-depth interviews with 10 compounding pharmacists and physicians who prescribe compounded prescription pharmaceutical preparations were conducted to help develop a self administered questionnaire distributed to 50 compounding and 50 noncompounding pharmacists. Compounding and non-compounding pharmacists’ perceptions differed most often in the context of compounded pharmaceuticals for pediatric patients. However, both groups responded with moderate agreement that compounded prescription treatments are more profitable for the pharmacy than commercial prescription treatments in most therapeutic areas. This research sought to understand the perception of pharmacists of areas for potential direct and indirect economic cost savings as a result of compounding. For all items whereby compounding and non-compounding pharmacists’ ratings were significantly different, compounding pharmacists more strongly believed that compounding pharmaceuticals offered benefit and vice versa. The differences in ratings that were most common were those that directly compared the economic value of compounding and commercial pharmaceuticals, with compounding pharmacists more strongly agreeing with the potential cost savings associated with compounded pharmaceuticals. Based on these findings, prescription compounds are believed to have a benefit to the health system by those who provide them. Future research should proactively explore the economic benefit of compounded preparations compared to conventionally manufactured products to determine the economic value of compounded pharmaceuticals for patients, pharmacies, physicians, and the healthcare system.

Related Keywords: William B. Lobb, RPh, PhD, Noel E. Wilkin, RPh, PhD, Erin R. Holmes, PharmD, PhD, pharmacist survey, pharmacist perceptions, compounded preparations, drug costs, patient satisfaction, drug cost savings, hormone replacement, HRT, skin disorders, high blood pressure, hypertension, pediatrics, children, hospice, compounding pharmacists, non-compounding pharmacists

Related Categories: BUSINESS, PEER-REVIEWED, PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Lobb William B, Wilkin Noel E, Holmes Erin R Nov/Dec 2015 514-520 Buy
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT DiMaggio Jennifer Lyn, Reed-Kane Dana Jul/Aug 2003 258 Buy
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Huffman DC, Holmes Erin R Jan/Feb 2008 74-82 Buy
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Huffman DC, Holmes Erin R Nov/Dec 2006 462-468 Buy
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update Hu Fei-Shu, Reed-Kane Danna, Draugalis JoLaine R May/Jun 2006 187-192 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc Jan/Feb 2014 6-12 Buy
Patient-centered Care as Value-added Service by Compounding Pharmacists McPherson Timothy B, Fontane Patrick E, Day Jonathan R Jul/Aug 2013 339-343 Buy
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Branvold Andrea, Barner Jamie C Nov/Dec 2003 490-494 Buy
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin May/Jun 2015 261-267 Buy